Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Drug Interaction Study Between Inhaled Beclomethasone and Protease Inhibitors in Healthy Volunteers.

Trial Profile

Drug Interaction Study Between Inhaled Beclomethasone and Protease Inhibitors in Healthy Volunteers.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 18 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Beclometasone (Primary) ; Darunavir; Ritonavir
  • Indications Asthma; HIV infections; Respiratory tract disorders
  • Focus Pharmacodynamics; Pharmacokinetics

Most Recent Events

  • 02 Jul 2017 Biomarkers information updated
  • 14 Mar 2012 Actual patient number changed from 30 to 53 as reported by ClinicalTrials.gov.
  • 14 Mar 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top